Clinical trial suggests immunotherapy before surgery is a potential new treatment for rare cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Dec-2025 13:11 ET (20-Dec-2025 18:11 GMT/UTC)
Results from an early phase clinical trial presented this week at the World Conference on Lung Cancer Meeting in Barcelona, Spain, and published in the Nature Medicine journal show that patients with mesothelioma - a rare cancer of the lining of the lung that may be caused by exposure to asbestos - who received a combination of two immunotherapy drugs, nivolumab and ipilimumab, before surgery had successful surgeries and encouraging early outcomes.
Discover how machine learning is helping researchers identify different groups of chronic obstructive pulmonary disease (COPD) patients in China and understand how their health conditions impact daily life. This new study offers insights into targeted treatments and better quality of life for those living with COPD.
Psychiatrists and mental health professionals have always relied on medication and talk therapy to treat depression, but Dr. Nicholas Fabiano, a psychiatry resident at the University of Ottawa, thinks it’s time for a shift. In an editorial for the British Journal of Sports Medicine, he argues that exercise shouldn’t be an afterthought, it should be a standard part of every treatment plan for patients with depression.